SGMO vs. ACRS
SGMO (Sangamo Therapeutics, Inc.) and ACRS (Aclaris Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Their 0.28 correlation means their historical movements had little consistent relationship.
Performance
SGMO vs. ACRS - Performance Comparison
Loading charts...
Returns By Period
SGMO
- 1D
- —
- 1M
- —
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
ACRS
- 1D
- -2.26%
- 1M
- -6.47%
- 6M
- 48.15%
- YTD
- 72.76%
- 1Y
- 239.87%
- 3Y*
- -19.07%
- 5Y*
- -19.02%
- 10Y*
- -12.11%
- ALL TIME*
- -7.40%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $8.58M | $9.53M | $8.25M |
SGMO vs. ACRS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SGMO Sangamo Therapeutics, Inc. | -82.38% | -58.82% | 87.74% | -82.70% | -58.13% | -51.94% | 86.44% | -27.09% | -30.00% | 437.70% |
ACRS Aclaris Therapeutics, Inc. | 72.76% | 21.37% | 136.19% | -93.33% | 8.32% | 124.73% | 242.33% | -74.42% | -70.03% | -9.14% |
Correlation
The correlation between SGMO and ACRS is 0.17, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.17 |
Correlation (3Y) Balances recent behavior with more history. | 0.24 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.32 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.28 |
Correlation (All Time) Calculated using the full available price history since Oct 7, 2015 | 0.28 |
The correlation between SGMO and ACRS shifts across timeframes, from 0.17 (1 year) to 0.32 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
SGMO:
$30.66M
ACRS:
$726.25M
SGMO:
-$0.36
ACRS:
-$0.56
SGMO:
0.74
ACRS:
77.50
SGMO:
$34.56M
ACRS:
$8.37M
SGMO:
$25.51M
ACRS:
$6.39M
SGMO:
-$106.29M
ACRS:
-$73.08M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SGMO vs. ACRS — Risk / Return Rank
SGMO
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
ACRS
SGMO vs. ACRS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sangamo Therapeutics, Inc. (SGMO) and Aclaris Therapeutics, Inc. (ACRS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SGMO | ACRS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.45 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 6.59 | — |
| Martin ratioReturn relative to average drawdown | — | 18.05 | — |
Loading charts...
Drawdowns
SGMO vs. ACRS - Drawdown Comparison
Loading charts...
Drawdown Indicators
| SGMO | ACRS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -98.05% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -36.64% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -93.45% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -96.57% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -98.05% | — |
Current DrawdownCurrent decline from peak | — | -84.24% | — |
Average DrawdownAverage peak-to-trough decline | — | -63.91% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 13.35% | — |
Volatility
SGMO vs. ACRS - Volatility Comparison
Loading charts...
Volatility by Period
| SGMO | ACRS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 14.22% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 44.25% | — |
Volatility (1Y)Calculated over the trailing 1-year period | — | 96.44% | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | — | 92.32% | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | — | 110.39% | — |
Dividends
SGMO vs. ACRS - Dividend Comparison
Neither SGMO nor ACRS has paid dividends to shareholders.
Financials
SGMO vs. ACRS - Financials Comparison
This section allows you to compare key financial metrics between Sangamo Therapeutics, Inc. and Aclaris Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SGMO and ACRS have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for SGMO and ACRS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer